Murex loses another round in dispute with Chiron
This article was originally published in Clinica
Executive Summary
Murex lost another round in its HCV patent infringement case with Chiron. The District Court of The Hague has issued an injunction preventing Murex from selling its HCV screening tests in the Netherlands, Belgium, France and Spain (see Clinica 635, p 14). Sales in Italy are unaffected by The Hague decision.